Bicycle Therapeutics Plc ADR (BCYC)

Feb 5, 2025, 7:00 AM EST - 17 days ago

Bicycle Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Feb 3, 2025, 4:05 PM EST - 19 days ago

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feb 2, 2025, 5:26 AM EST - 20 days ago

Bicycle Therapeutics: Trading At Cash, Underwhelming But Not Unsalvageable Data

Jan 13, 2025, 7:00 AM EST - 5 weeks ago

Bicycle Therapeutics Announces Updated Topline Zelenectide Pevedotin Data and Highlights 2025 Strategic Priorities and Milestones

Jan 9, 2025, 7:00 AM EST - 6 weeks ago

Bicycle Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Dec 12, 2024, 6:30 PM EST - 2 months ago

Bicycle Therapeutics Announces Data Updates Across Zelenectide Pevedotin Program and Development Strategy Leveraging NECTIN4 Gene Amplification

Dec 10, 2024, 7:00 AM EST - 2 months ago

Bicycle Therapeutics Expands Clinical Advisory Board with Three Distinguished Global Oncology Experts

Nov 25, 2024, 5:30 PM EST - 3 months ago

Bicycle Therapeutics to Present Data for Zelenectide Pevedotin at 2024 San Antonio Breast Cancer Symposium and Provide Program Update

Nov 12, 2024, 7:00 AM EST - 3 months ago

Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference

Nov 7, 2024, 10:04 AM EST - 3 months ago

Bicycle Therapeutics: Looking Again At An Intriguing Developmental Concern

Oct 31, 2024, 7:00 AM EDT - 4 months ago

Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results

Oct 23, 2024, 7:00 AM EDT - 4 months ago

Bicycle Therapeutics Announces First Human Imaging Data from European Association of Nuclear Medicine 2024 Congress and Outlines Strategy for Leadership in Next-Generation Radiopharmaceuticals

Oct 16, 2024, 7:00 AM EDT - 4 months ago

Bicycle Therapeutics to Present Radiopharmaceuticals Data at European Association of Nuclear Medicine 2024 Congress

Sep 14, 2024, 3:00 AM EDT - 5 months ago

Bicycle Therapeutics Presents Updated Clinical Results Across Oncology Pipeline at ESMO Congress 2024

Sep 6, 2024, 1:37 PM EDT - 6 months ago

Bicycle Therapeutics' Lead Cancer Candidate's Has High-Opportunity, Analyst Initiates With Bullish Tone

Aug 21, 2024, 7:00 AM EDT - 6 months ago

Bicycle Therapeutics to Participate in Upcoming Investor Conferences

Aug 20, 2024, 7:37 AM EDT - 6 months ago

Bicycle Therapeutics Is Looking Increasingly Attractive

Aug 6, 2024, 7:05 AM EDT - 7 months ago

Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial Results

Aug 6, 2024, 7:00 AM EDT - 7 months ago

25 Snack Food Suppliers Queue Up for ReposiTrak's Rapidly Expanding Food Traceability Network

BSY MASS MLI NJR OFIX QBTS SMMT

Jul 22, 2024, 7:00 AM EDT - 7 months ago

Bicycle Therapeutics Announces Four Abstracts Accepted for Presentation at the ESMO Congress 2024

May 23, 2024, 5:05 PM EDT - 9 months ago

Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting

May 23, 2024, 7:00 AM EDT - 9 months ago

Bicycle Therapeutics Announces $555 Million Private Placement Equity Financing

May 2, 2024, 7:00 AM EDT - 10 months ago

Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results

Apr 24, 2024, 10:05 AM EDT - 10 months ago

Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting

Apr 2, 2024, 7:00 AM EDT - 11 months ago

Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Mar 25, 2024, 1:07 PM EDT - 11 months ago

2 More Potential Biotech Buyout Targets

AZN BMY EXEL LLY MRK NVS TAK

Mar 12, 2024, 12:09 PM EDT - 1 year ago

Bicycle: 2nd Half Of 2024 Data Could Provide Significant Inflection Point

Mar 5, 2024, 4:35 PM EST - 1 year ago

Bicycle Therapeutics to Present at the AACR Annual Meeting 2024

Feb 20, 2024, 7:05 AM EST - 1 year ago

Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results

Feb 7, 2024, 7:00 AM EST - 1 year ago

Bicycle Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Dec 14, 2023, 7:00 AM EST - 1 year ago

Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day

Nov 30, 2023, 7:00 AM EST - 1 year ago

Bicycle Therapeutics to Host R&D Day on December 14

Nov 2, 2023, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results and Announces Upcoming R&D Day

Oct 19, 2023, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics Selected to Participate in FDA Program to Expedite Commercial Manufacturing Readiness of BT8009 for Metastatic Bladder Cancer

Oct 19, 2023, 4:00 AM EDT - 1 year ago

Macomics Announces the Appointment of Kevin Lee as Independent Non-Executive Director

Sep 11, 2023, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics Announces Expedited Development Plan for BT8009 in Metastatic Bladder Cancer

Sep 5, 2023, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

Aug 3, 2023, 6:59 AM EDT - 1 year ago

Bicycle Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Jul 31, 2023, 7:07 PM EDT - 1 year ago

Bicycle Therapeutics: Decent Upside Opportunity, Mid-Stage Data Readouts Due

Jul 18, 2023, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics Announces Closing of Public Offering of American Depositary Shares and Non-Voting Ordinary Shares and Full Exercise of Underwriters' Option to Purchase Additional Shares

Jul 12, 2023, 10:23 PM EDT - 1 year ago

Bicycle Therapeutics Announces Pricing of $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares

Jul 12, 2023, 4:01 PM EDT - 1 year ago

Bicycle Therapeutics Announces Proposed $200 Million Public Offering of American Depositary Shares and Non-Voting Ordinary Shares

Jun 23, 2023, 7:30 AM EDT - 1 year ago

Bicycle Therapeutics Appoints Alethia Young as Chief Financial Officer

Jun 13, 2023, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics to Participate in the TD Cowen Radiopharmaceutical Innovation Summit

May 31, 2023, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics to Participate in the Jefferies Healthcare Conference

May 14, 2023, 7:16 AM EDT - 1 year ago

Bicycle Therapeutics: Not Much Differentiation Between Bicycles And mAbs Yet

May 11, 2023, 6:59 AM EDT - 1 year ago

Bicycle Therapeutics and Orano Med Present Preclinical Bicycle® Radio-Conjugate Data at TIDES 2023

May 10, 2023, 8:00 AM EDT - 1 year ago

Bayer and Bicycle Therapeutics Enter Strategic Collaboration for Development of Novel Targeted Radionuclide Therapies in Oncology

May 4, 2023, 7:00 AM EDT - 1 year ago

Bicycle Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update

May 4, 2023, 6:45 AM EDT - 1 year ago

Bicycle Therapeutics Announces Collaboration With the German Cancer Research Center, to Discover and Develop Wholly Owned Bicycle® Radio Conjugates for a Range of Oncology Targets